Jeremy Davis - Apr 20, 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
SVP Chief Commercial Officer
Signature
/s/ Jeremy Davis by Nicholas Khadder, Attorney-in-Fact
Stock symbol
LAB
Transactions as of
Apr 20, 2022
Transactions value $
$0
Form type
4
Date filed
4/21/2022, 06:21 PM
Previous filing
Apr 6, 2022
Next filing
Jan 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Award $0 +250K $0.00 250K Apr 20, 2022 Common Stock 250K Direct F1, F2

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2 Restricted Stock Units vest as to 1/4th of the underlying shares on May 20, 2023, and as to an additional 1/16th of the total number of shares each quarter thereafter.